January 17, 2025

Patient Care Declines After PE Acquisition

A recent study reveals that patient-reported care experience declined significantly at hospitals acquired by private equity firms, highlighting the potential impact of private equity acquisitions on patient care.

Conexiant

January 16, 2025

USPSTF Adds Health Equity, Maternal Care Experts

New members, Alicia Fernandez, MD, and Ericka Gibson, MD, MPH, bring expertise in health equity and maternal health care to the U.S. Preventive Services Task Force, contributing to evidence-based recommendations about clinical preventive services such as screenings, and counseling services.

Conexiant

January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

January 15, 2025

Cutaneous Head and Neck Melanoma: Better Outcomes with ICIs

Explore the distinct clinicopathological features and treatment outcomes of cutaneous head and neck melanoma versus other melanoma sites.

Conexiant

January 15, 2025

Unburned Homes Post-Wildfire Pose Risks

People with smoke or ash damaged homes reported more physical health symptoms six months postfire than those in nondamaged homes.

Reuters

January 14, 2025

Allergic Multimorbidity Linked to Mucosal Healing in UC

Patients with 3+ allergic conditions had 8x higher odds of achieving mucosal healing, highlighting potential shared immune pathways.

Conexiant

January 14, 2025

Remnant Cholesterol as Biomarker for Endometriosis, Study

‘An increase of one unit in RC was linked to a 135% rise in the likelihood of developing endometriosis,’ positioning remnant cholesterol as a promising marker for risk assessment.

Conexiant

January 13, 2025

Vitiligo Treatment: ASCS vs. NB-UVB

Autologous skin cell suspension therapy demonstrates effective and durable repigmentation for stable vitiligo, showing higher repigmentation rates compared to narrow-band ultraviolet B therapy alone.

Conexiant

January 13, 2025

JAK Inhibitors & RZV Vaccination Timing: Study Underway

"The risk of developing herpes zoster is confirmed in almost all studies regarding JAK inhibitors."

Conexiant